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Abstract
Purpose:  To  study  the  diagnostic  value  of  static  elastography  of  the  breast  (score,  histogram,
quantitative  ratio)  in  masses  classed  as  BI-RADS  4  and  BI-RADS  5  on  sonography  using  the  ﬁndings
from pathological  anatomy  analyses  on  the  masses  as  a  reference.
Materials  and  methods:  A  prospective  study  using  a  representative  sample  into  68  masses  seen
on sonography  and  their  elastography  results.  For  each  mass,  we  determined  the  elastogra-
phy colourimetry  score  (UENO  et  al.  classiﬁcation,  scores  1—3  =  benign  and  4—5  =  malignant).
We studied  quantitative  elastography  parameters  based  on  the  Z2/Z1  (fat/lesion)  ratio  and  a
histogram showing  the  pattern  of  mass  stiffness  distribution.  The  results  were  compared  with
histology  ﬁndings  (68  lesions  assessed,  22  benign  lesions  and  46  malignant  lesions).
Results:  Elastography  was  consistent  with  histology  (sensitivity:  73.9%,  speciﬁcity:  86.4%,  PPV:
91.9%, NPV:  61.3%).  There  were  twelve  false  negatives  and  three  false  positives.  With  the  Z2/Z1
ratio, we  set  a  cut-off  point  of  3.05  for  99.0%  speciﬁcity.
Conclusion:  Elastography  is  a  reliable  technique  that  is  able  to  assist  radiologists  in  their  diag-
nostic approach  to  breast  pathology.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.Breast  cancer  is  the  leading  cause  of  cancer  deaths  in  women  in  industrialised  countries
and  its  incidence  continues  to  escalate.  There  are  three  imaging  techniques  that  are  avail-
able  to  radiologists  to  detect  breast  cancer:  mammography  is  the  reference  technique,
while  sonography  and  MRI  are  considered  by  be  complementary  imaging  methods.  B-mode
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•58  
onography  is  an  indispensable  complementary  examination
or  the  investigation  of  breast  masses,  whether  they  are  pal-
able  or  not,  with  98.4%  sensitivity  [1—3]. Its  major  strength
s  its  ability  to  differentiate  ﬂuid-ﬁlled  lesions  from  solid
esions.  Its  speciﬁcity  is  greater  than  that  of  mammogra-
hy  although  it  still  remains  below  50%  (47.5%)  [1]  and  the
rawback  is  that  it  is  dependent  on  the  observer  [4—7],
heir  experience,  and  the  quality  of  the  equipment  used.
s  with  mammography  and  MRI,  the  interpretation  of  breast
issue  nodules  found  on  B-mode  sonography  relies  on  criteria
f  symptomatology  and  morphology.  Masses  are  categorised
sing  the  BI-RADS  tool  published  by  the  American  College
f  Radiology  (ACR),  which  ranks  masses  from  0  to  6  [8].
his  classiﬁcation  can  be  reﬁned  by  integrating  additional
riteria,  such  as  tissue  stiffness.  Elastography  is  able  to
nalyse  differences  in  tissue  elasticity  [9].  A  benign  lesion
s  normally  ﬁrmer  than  the  surrounding  breast  tissue  but
ofter  than  a  malignant  lesion  [10]. This  is  explained  by
he  concept  of  the  elastic  modulus  or  Young’s  modulus,  a
onstant  that  links  the  compression  strain  with  the  defor-
ation  of  an  elastic  material  where   = E (  is  the  strain
in  units  of  pressure),  E  is  the  Young  modulus,  ε  is  the  rel-
tive  change  in  length).  The  stiffness  of  a  malignant  nodule
an  also  be  explained  by  the  ﬁbrous  desmoplastic  reaction
hat  it  provokes  [11,12].
There  are  two  types  of  elastography:  static  elastogra-
hy,  a  qualitative  technique  that  is  more  widely  used  than
ynamic  elastography,  which  is  a  new  quantitative  tech-
ique  using  the  shear  wave  generated  by  the  transducer
tself.  In  static  elastography,  the  imaging  transducer  is  used
o  compress  the  tissues.  A  programme  that  calculates  the
train  allows  the  differences  in  elasticity  from  one  tissue  to
nother  to  be  visualised  in  real  time  by  displaying  a  colour
ap  superimposed  on  the  B-mode  image.  This  technique
herefore  depends  on  the  compression  motion  applied  to  the
robe:  it  is  qualitative.  The  information  collected  is  repre-
ented  by  a  colour  scale  that  indicates  minimal  displacement
stiff  tissue)  to  maximum  displacement  (soft  tissue).  Elas-
ography  is  not  a  new  technique  [13]  but  it  is  not  often
sed.  Several  published  studies  have  shown  it  has  equivalent
ensitivity  to  B-mode  sonography  with  greater  speciﬁcity
1,14—17].  Elastography  allows  lesions  to  be  classiﬁed  as
enign  or  malignant  depending  on  the  stiffness  of  the  tis-
ue  studied  using  a  colourimetric  score  and  a  quantitative
ssessment.  The  colourimetric  score  is  used  to  categorise
he  lesion  following  UENO  et  al.  with  scores  from  1  to  3
onsidered  to  be  benign  and  scores  of  4  and  5  considered
o  be  malignant  (Fig.  1)  [16]. A  semi-quantitative  value  is
btained,  which  is  the  ratio  of  the  stiffness  of  the  tissue
tudied  to  the  stiffness  of  the  fatty  tissue.  This  means  that
esions  can  also  be  differentiated  in  terms  of  how  aggres-
ive  they  are,  and  this  value  has  not  been  widely  studied
n  the  literature.  While  very  high  numbers  of  mammograms
nd  sonograms  are  carried  out  in  France,  few  centres  are
quipped  with  breast  elastography  systems.
The  cost  of  equipment  could  be  the  factor  limiting  the
idespread  use  of  this  technique.  Moreover,  carrying  out
lastography  requires  technicians  to  undergo  a  learning
rocess  that  could  pose  constraints  on  the  daily  practice
f  breast  radiologists.  However,  elastography  is  a  simple,
uick,  and  non-invasive  technique  that  may  be  useful  for
ssessing  solid,  non-palpable  breast  lesions,  primarily  thoseigure 1. Elastography colourimetry classiﬁcation established by
rofessor Ueno based on the degree of suspicion for malignancy.
lassed  as  BI-RADS  3  and  4  [8,17]. The  principal  objective  of
his  study  is  to  assess  the  diagnostic  value  of  static  elastog-
aphy  of  the  breast  (score,  histogram,  quantitative  ratio)
n  masses  classed  as  BI-RADS  4  and  BI-RADS  5  on  sonogra-
hy,  using  the  ﬁndings  from  the  pathology  analyses  on  these
asses  as  a  reference.
aterials and methods
his  prospective  study  took  place  from  March  2011  to  June
011.  Four  different  operators  took  part  in  the  study,  and
ach  one  had  been  given  two  days  of  practical  training  in
sing  the  equipment.  The  engineer  explained  the  principle
f  elastography  to  each  operator  before  the  start  of  their
sual  shift  in  the  breast  department.  Then  elastography  as  a
omplementary  investigation  was  routinely  carried  out  with
he  engineer’s  assistance  on  each  patient  who  had  given  her
rior  consent  (15  patients  on  average).  A  second  day,  one
eek  later,  was  scheduled  in  order  to  check  that  the  opera-
or  was  correctly  using  the  equipment.  The  operators  carried
ut  breast  elastography  on  a  daily  basis,  in  each  patient  who
ad  a  mass  shown  on  sonography  during  the  three  months
efore  the  study  began.
atients
he  study  included  68  patients  with  masses  found  on  sonog-
aphy  that  were  classiﬁed  as  BI-RADS  4  and  BI-RADS  5
ollowing  the  ACR’s  sonography  classiﬁcation  system  [8].
he  masses  were  discovered  during  a  screening  programme,
outine  investigations  or  investigations  into  a  clinical  abnor-
ality.  For  each  patient  we  listed:
the  individual  variables:
◦ age,
◦ personal  history  of  breast  cancer,
◦ family  history  of  breast  cancer,
◦ the  menopause  and  use  of  hormone  replacement  ther-
apy  (HRT);
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be expressed  using  standard  deviation  (Fig.  2).  From  the
information  collected  a  histogram  could  be  drawn  up  that
showed  the  distribution  of  breast  tissue  stiffness  within  two
regions  of  interest  on  a  scale  of  0  to  100  (Fig.  3).  For  each
elastography,  the  following  were  recorded:
• colourimetric  score:  1,  2,  3,  4  or  5  following  the  classi-
ﬁcation  of  UENO  et  al.  (Fig.  1);  scores  from  1  to  3  being
considered  to  indicate  a benign  lesions  and  scores  4  and
5  malignant  lesions  [16];
• quantitative  result:  the  ROI  ratio,  i.e.  the  fat-lesion  ratio
(Z2/Z1);
• data  from  the  histogram  of  the  lesion:  the  predominant
column  for  lesion  stiffness,  whether  1,  2,  3,  4,  or  5.
Histology
Lesion  specimens  for  pathological  analysis  were  obtained
by  percutaneous  ﬁne-needle  biopsy  alone  or  in  combination
Figure 2. Elastography study. The colour map during an elastog-
raphy study. The ﬁgure on the bottom right of the image allows
the user to check they are correctly carrying out the compression-
decompression manoeuvre. The ﬁrst ROI (Z1) is marked in the lesion
and the second ROI (Z2) is marked in the subcutaneous fat allowing
the Z2/Z1 ratio to be calculated. In this example it is calculated to
be 5.35.An  assessment  of  the  performance  of  elastography  
• clinical  ﬁndings:
◦ palpable  mass,
◦ non-palpable  mass.
The  inclusion  and  exclusion  criteria  in  this  study  were:
• inclusion  criteria:  patients  with  a  mass  found  on  sonog-
raphy  classed  as  BI-RADS  4  or  5  and  who  have  had
elastography  and  a  sample  taken  for  histological  exam-
ination;
• exclusion  criteria:  patients  with  masses  that  have  not
been  biopsied,  masses  classed  as  BI-RADS  2  or  3  accord-
ing  to  the  ACR’s  sonography  classiﬁcation  system  [8],
extra-mammary  masses  (in  the  post-mastectomy  chest
wall  or  the  lymph  nodes),  patients  having  neoadjuvant
chemotherapy  for  a  contralateral  or  adjacent  lesion.
B-mode sonography
The  sonography  studies  were  carried  out  by  four  different
operators  on  an  Esaote  Mylab  70© ultrasound  system  commis-
sioned  in  April  2006,  equipped  with  two  linear  transducers
from  10  to  18  MHz.  Of  these  four  operators,  one  was  a  radi-
ologist  specialised  in  imaging  in  women’s  health  with  ten
years  experience  of  sonography  and  a  small  amount  of  expe-
rience  of  elastography  and  three  radiologists  specialised  in
imaging  in  women’s  health  whose  sonography  experience
ranged  from  two  to  four  years  but  who  had  no  experience
of  elastography.  Each  mass  was  categorised  according  to  the
ACR’s  sonography  classiﬁcation  system  (BI-RADS)  [8]  taking
into  account  its  shape,  margins,  echogenicity,  and  posterior
acoustic  features.  The  largest  measurement  in  millimetres
(mm)  was  retained  after  the  mass  was  measured  across  all
three  axes.
Elastography
Elastography  studies  were  carried  out  during  sonography  of
the  lesions  using  the  elastography  function  of  the  Esaote
Mylab  70 © ultrasound  system.  Each  operator  had  been  given
two  days  of  training  with  patients.  The  ultrasound  probe  was
placed  perpendicular  to  the  skin  opposite  the  lesion  to  be
investigated  with  the  breast  uniformly  ﬂattened.  Then  the
operator  carried  out  a  repeated  series  of  compressions  and
decompressions  using  successive  uniform  movements  with
the  probe  placed  in  the  centre  of  the  lesion.  The  operator
was  able  to  check  that  he/she  was  applying  suitable  pres-
sure  by  looking  at  a  pressure  scale  on  the  screen  visible  in
real  time.  The  acquisition  was  taken  on  decompression.  Two
screens  were  used  with  the  B-mode  sonography  image  of  the
lesion  on  the  left  and  the  corresponding  elastography  colour
map  on  the  right,  thus  assisting  the  operator  in  ﬁnding  the
correct  position.  The  information  collected  was  represented
by  a  colour  scale  that  encoded  minimal  displacement  as  blue
(stiff  tissue)  ranging  up  to  maximum  displacement  encoded
as  red  (soft  tissue).  In  this  way,  a  colour  map  was  created  and
the  lesion  could  be  categorised  following  the  classiﬁcation
proposed  by  UENO  et  al.  (Fig.  1)  [16].
In  order  to  carry  out  the  quantitative  assessment,  we
marked  the  regions  of  interest  (ROI)  on  the  colour  map
obtained.  The  ﬁrst  ROI  was  marked  in  the  lesion  (zone  Z1)
and  the  second  ROI  in  the  subcutaneous  fat  (Z2).  The  ratio
of  Z2  to  Z1  (Z2/Z1)  meant  that  an  elastography  ratio  could
Figure 3. Histogram showing the distribution pattern of tissue
stiffness within the two regions of interest on a scale of 0 to 100
divided into ﬁve columns. In this example, lesion stiffness is dis-
tributed widely, pointing to a soft lesion.
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74 Fine-needle biopsies
69 Elastography studies 5 Elastography studies not done *
1 Excluded **
68 Analysed
46 Malignant lesions 22 Benign lesions
* Elastography studies not done at the time ofthe fine -needle biopsy of the breast because 
the doctors carrying out the intervention forgot. 
** Patient excluded because of an error positioning the reference ROI in the subcutaneous fat 
(Z2) during the elastography study.
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ith  surgical  excision  when  the  lesion  was  malignant.  This
s  considered  to  be  the  gold  standard  examination.  These
ltrasound-guided  biopsies  used  a  strict  aseptic  technique
the  skin  was  disinfected  with  betadine  or  chlorhexidine)
nd  local  anaesthesia  with  lidocaine.  We  used  a  biopsy  sys-
em  with  14,  16  or  18  gauge  needles  (Bard  system).  We
outinely  removed  three  specimens  per  mass.  The  fragments
btained  by  percutaneous  ﬁne-needle  biopsy  and  the  spec-
mens  from  the  lumpectomy,  tumourectomy  or  mastectomy
btained  after  surgery  were  examined  in  the  pathological
natomy  laboratory  in  order  to  deﬁne  the  histology  of  the
esion.  Based  on  the  pathology,  results  lesions  were  classed
ither  as  benign  or  malignant.  Where  lesions  had  been  oper-
ted  on,  the  diagnosis  of  malignancy  was  conﬁrmed  by
nalysing  the  excised  specimen.  The  histologic  type  of  each
alignant  lesion  was  deﬁned.
ata analysis
ur  study  covered  a  representative  sample.  The  elastog-
aphy  results  were  compared  to  the  histology  data  using
 non-matched  Student’s  t  test  and  a  non-parametric
ilcoxon’s  test.  The  diagnostic  performance  of  elastogra-
hy  was  expressed  in  terms  of  sensitivity,  speciﬁcity,  positive
redictive  value  (PPV)  and  negative  predictive  value  (VPN)
s  compared  to  histology.  The  diagnostic  values  of  the
lastography  colourimetric  score  and  the  quantitative  ratio
ere  assessed  using  the  ROC  curves  method  for  different
hresholds  of  colourimetric  score  and  quantitative  ratio.  We
arried  out  an  analysis  of  covariance  studying  the  ACR  cat-
gory,  colourimetry,  and  the  benign  and  malignant  lesions.
or  all  the  tests,  a  P  value  of  <  0.05  was  taken  as  the  signif-
cance  threshold.
esults
low  chart  of  the  representative  sample  study  that  took
lace  from  March  2011  to  June  2011  (Fig.  4).  Table  1  sum-
arises  the  results  of  the  study  in  terms  of  the  histology  of
he  biopsied  masses.
haracteristics of the patients in the sample
he  mean  age  of  the  patients  was  59  years,  ranging
rom  18  to  85  years.  30.9%  of  the  included  patients
ere  drawn  from  organised  screening  programmes,  while
9.1%  of  cases  were  found  during  investigation  of  a
ass  or  some  other  clinical  symptomatology.  Among  the
atients,  79.4%  had  no  personal  history  of  cancer,  86.8%
ad  no  family  history  of  breast  cancer,  72.1%  were  post-
enopausal  and  of  these,  20.6%  had  been  treated  with
RT.
ata from B-mode sonography of 68 masses
he  size  of  the  lesions  found  on  sonography  ranged
rom  3  to  70  mm  (mean  =  13.7  mm)  and  4.4%  of  masses
ere  smaller  than  5  mm.  Twenty-ﬁve  masses  (36.8%)  were
lassed  as  BI-RADS  category  4  and  43  (63.2%)  as  BI-RADS
.
l
c
t
5igure 4. Flow chart of the representative sample study that took
lace from March 2011 to June 2011.
ata from elastography of 68 masses
he  68  lesions  studied  were  categorised  based  on  colourime-
ry,  with  a  score  of  2  in  14  cases  (20.6%),  3  in  17  cases
25.0%),  4  in  seven  cases  (10.3%),  and  5  in  30  cases
44.1%).  In  total,  there  were  31  lesions  scored  as  2  and
 and  considered  to  be  benign,  making  up  45.6%  of  the
ample,  and  the  37  cases  scored  as  4  and  5  and  consid-
red  to  be  malignant  made  up  54.4%  of  the  sample.  The
2/Z1  ROI  ratio  ranged  from  0.3  to  7.4  with  a  mean  of
.4.
Column  1  of  the  histogram  was  the  largest  in  44  cases  or
4.7%,  column  2  in  14  cases  (20.6%),  column  3  in  seven  cases
10.3%),  column  4  in  one  case  (1.5%),  column  5  in  two  cases
2.9%).
athology diagnosis of 68 lesions
orty-six  lesions  were  malignant  (67.6%)  and  22  lesions  were
enign  (32.4%)  (Table  2).
iagnostic performance of elastography
lastography  colourimetry  scores  of  the  sample
n  =  68)  compared  to  histology:  of  the  46  malignant  lesions,
4  lesions  (73.9%)  had  a colourimetry  score  of  4  or  5  and
2  (26.1%)  had  a  colourimetry  score  of  1,  2  or  3.  Of  the  22
enign  lesions,  19  lesions  (86.4%)  had  a  score  of  1,  2  or  3  and
hree  (13.6%)  scored  4  or  5.  (Table  3).  The  histology  results
f  the  12  false  negatives  found  on  elastography  showed  six
nvasive  ductal  carcinomas  (grade  I  =  2,  grade  II  = 3,  grade
II  =  1),  two  invasive  lobular  carcinomas  (grade  II  =  2),  one
ucinous-type  cancer,  one  ductal  carcinoma  in  situ,  one
ymph  node  tumour  proliferation  and  1  B-cell  lymphoma
ocalised  to  the  breast.  Five  of  these  false  negatives  were
lassed  as  BI-RADS  4  (Fig.  5).  The  histology  results  of  the
hree  false  positives  found  on  elastography  (three  scores  of
)  showed  one  sclerosing  adenosis,  one  radial  scar  and  one
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Table  1  Characteristics  of  the  benign  and  malignant  lesion  groups:  demographics,  sonography,  and  elastography.
Benign(n  =  22)  %  Malignant(n =  46)  %  Total (n  =  68)  %
Age 53  (30—80)  61  (18—85)  59  (18—85)
Personal  history  7  31.8  7  15.2  14  20.6  P  =  0.113
Family  history  4  18.2  5  10.9  9  13.2  P  =  0.405
Screening  3  13.6  18  39.1  21  30.9  P  =  0.033
Post-menopausal  12  54.5  37  80.4  49  72.1  P  =  0.026
Used  HRT  3  13.6  11  23.9  14  20.6  P  =  0.327
Palpable  mass 12 54.5  26 56.5 38  55.9  P  =  0.878
Sonography
ACR  4  16  72.7  9  19.5  25  36.8  P  =  0.0001
ACR  5  6  27.3  37  80.4  43  63.2
Colourimetry  score
2 10  45.5  4  8.7  14  20.6  P  =  0.0001
3 9 40.9  8  17.4  17  25.0
4 0  0.0  7  15.2  7  10.3
5 3 13.6  27  58.7  30  44.1
Benign  (1,  2,  3)  19  86.4  12  26  31  45.6  P  =  0.0001
Malignant  (4,  5) 3 13.6 34  74  37  54.4
ROI  ratio
< 4.3  20  90.9  22  47.8  42  61.8  P  =  0.001
≥  4.3  2  9.1  24  52.2  26  38.2
Mean  1.7  (SD:  1.3)  4.2  (SD:  1.9)  3.4  (SD:  2.1)
Histogram
Column  1  5  22.7  39  84.7  44  64.7  P  =  0.0001
Column  2,  3,  4,  5  17  77.3  7  15.2  24  35.3
SD: standard deviation.
Table  2  Histological  diagnosis  of  the  68  lesions  analysed.
Benign  lesions  (n  =  22)  Malignant  lesions  (n  =  46)  %
Benign  lesionsa =  8  Invasive  ductal  carcinoma  =  31
Fibroadenoma  =  5  Grade  I  =  11  35.5
Cyst  =  2  Grade  II  =  14  45.2
Papilloma  =  2  Grade  III  =  6  19.3
Radial  scar  =  2  Invasive  lobular  carcinoma  =  7
Sclerosing  adenosis  =  1  Grade  I  =  1  14.3
Granular  cell  tumour  =  1  Grade  II  =  4  57.1
Fat  necrosis  =  1  Grade  III  =  2  28.6
Papillary  carcinoma  =  2
Mucinous  carcinoma  =  1
Apocrine  carcinoma  =  1
B-cell  lymphoma  =  2
Ductal  carcinoma  in  situ  =  2
a Diagnosis of non-malignancy with no speciﬁc lesion.
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Table  3  Diagnostic  performance  of  elastography  colourimetry  score  (category  1—3  =  benign  and  4—5  =  malignant)  com-
pared  to  histology  ﬁndings.
Histology  Malignant  nodules(n  =  46)  Benign  nodules(n  =  22)  Total  %
Colourimetry
Malignant  (4  and  5)  34  3  37  PPV  =  91.9
Benign  (1  to  3) 12  19  31  NPV  =  61.3
Total 46 22  68
% Sensitivity  =  73.9 Speciﬁcity  =  86.4
Figure 5. A false negative on elastography. Mass measuring 16.7 mm (histology: large B-cell lymphoma localised to the breast): a: category
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t on the ACR sonography tool BI-RADS; b: benign elastography colour
ispersion suggestive of a soft lesion.
reast  that  was  the  site  of  inﬂammatory  changes.  These
esions  were  classed  as  BI-RADS  5  on  B-mode  sonography
Fig.  6).
The  results  of  our  study  show  that  elastography
olourimetry  score  has  an  increased  sensitivity  (73.9%)  and
peciﬁcity  (86.4%)  as  well  as  a  higher  PPV  of  91.9%  (Table  3)
ith  an  ROC  curve  showing  a  wide  area  under  the  curve  of
.813  (conﬁdence  interval  of  95%)  (Fig.  7).  Of  68  lesions,  43
odules  (63.2%)  were  classed  as  BI-RADS  5,  and  25  as  BI-RADS
 (36.8%).
Comparing  the  elastography  colourimetry  score  of  theI-RADS  5  masses  to  the  histology  results,  we  found  the
ollowing:  of  the  43  lesions  classed  as  BI-RADS  5,  histol-
gy  showed  37  malignant  lesions  and  six  benign  lesions
r
a
sry score of 2; c: histogram of tissue stiffness distribution: signiﬁcant
Table  4).  Histology  results  of  the  six  false  positives  found  on
onography  (classed  as  BI-RADS  5  but  histology  was  benign)
ound  one  benign  lesion,  one  sclerosing  adenosis,  one  radial
car,  one  granular  cell  tumour,  one  case  of  adipose  tissue
brosis  and  one  breast  that  was  the  site  of  inﬂamma-
ory  changes.  Of  these  six  false  positives,  the  elastography
olourimetry  score  was  concordant:  one  lesion  scored  as
 (the  benign  lesion)  meaning  it  was  a  soft  lesion,  two
esions  scored  as  3,  having  soft  consistencies  (the  granu-
ar  cell  tumour  and  the  case  of  adipose  tissue  ﬁbrosis),  and
hree  lesions  were  scored  as  5  (the  sclerosing  adenosis,  the
adial  scar  and  the  inﬂammatory  changes)  of  which  two  had
 stiffer  consistency  (the  sclerosing  adenosis  and  the  radial
car).
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Figure 6. False positive on elastography (histology: inﬂammatory changes): a: B-mode sonography: hypoechoic mass with irregular margins
classed as BI-RADS category 5 and elastography: the entire lesion and its periphery are coded in blue: score of 5; b: column 1 of the histogram
is the largest pointing to a stiff lesion.
Table  4  Performance  of  elastography  colourimetry  score  in  masses  classed  as  ACR  5  compared  to  histology  ﬁndings
(n  =  43).
Histology Malignant  nodulesn  =  37 Benign  nodulesn  =  6  Total  %
Colourimetry
Malignant  (4  and  5)  30  3  33  PPV  =  91.0
Benign  (1  to  3)  7  3  10  NPV  =  30.0
Total 37 6  43
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Of  the  25  lesions  classed  as  BI-RADS  4,  histology  revealed
16  benign  lesions  and  nine  malignant  lesions  (Table  5).  Of
the  nine  malignant  lesions,  four  were  invasive  ductal  car-
cinomas,  two  were  ductal  carcinomas  in  situ,  one  was  an
invasive  lobular  carcinoma,  one  was  a  large  B-cell  lym-
phoma  localised  to  the  breast  and  one  was  a  lymph  node
tumour  proliferation.  The  corresponding  elastography  score
fell  under  benign  with  a  score  of  2  for  the  two  lymphomas
and  3  for  the  invasive  lobular  carcinoma,  which  had  a  slightly
less  stiff  consistency.
Analysis  of  the  Z2/Z1  ratios  of  the  sample  based  on
elastography  data  (n  = 68)
The  ROI  ratios  ranged  from  0.3  to  7.4  with  a  mean  value  of
3.4.  The  higher  the  Z2/Z1  ratio,  the  more  likely  the  histology
results  would  show  a  malignant  lesion,  with  a  mean  ratio  of
2
u
m
a
Table  5 Performance  of  elastography  colourimetry  score  in  
(n  =  25).
Histology Malignant  nodulesn  =  9  
Colourimetry
Malignant  (4  and  5)  4  
Benign  (1  to  3)  5  
Total 9  
% Sensitivity  =  44.4  Speciﬁcity  =  50.0
.2  for  malignant  lesions,  and  the  lower  the  Z2/Z1  ratio,
he  more  likely  it  was  that  the  histology  results  would  show
 benign  lesion,  with  a  mean  ratio  of  1.7  for  benign  lesions.
wenty-four  malignant  lesions  of  the  46  (52.2%)  found  in  the
tudy  had  a  Z2/Z1  ratio  higher  than  or  equal  to  4.3.  The
orresponding  ROC  curve  (Fig.  8)  showed  a larger  area  under
he  curve  of  0.860  (95%  CI).
nalysis  of  the  histogram  encoding  the  distribution
f tissue  stiffness  of  the  sample  (n  = 68)
he  malignant  lesions  had  a  mean  value  of  1.20  in  their
argest  column.  The  benign  lesions  had  a  mean  value  of
.4  in  their  largest  column.  Of  the  44  cases  in  which  col-
mn  1  of  the  histogram  was  the  largest,  39  (84.7%)  were
alignant  lesions.  The  ﬁve  false  positives  corresponded  to
 radial  scar,  one  ﬁbroadenoma,  one  lesion  that  was  the
masses  classed  as  ACR  4  compared  to  histology  ﬁndings
Benign  nodulesn  =  16  Total  %
0  4  PPV  =  100.0
16  21  NPV  =  76.2
16  25
Speciﬁcity  =  100.0
764  
Figure 7. ROC curve of elastography colourimetry score com-
pared to histology ﬁndings.
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literature.  Our  study  did  ﬁnd  a  good  correlation  betweenigure 8. ROC curve of the Z2/Z1 elastography ratio compared
o histology ﬁndings.
ite  of  granulomatous  inﬂammatory  changes,  one  breast
ith  no  suspicious  ﬁndings  and  one  breast  with  dystrophic
arenchyma  and  no  atypical  ﬁndings.
iscussion
ased  on  the  results  of  this  study,  we  can  estimate  the  diag-
ostic  value  of  elastography  because  a  good  correlation  was
ound  between  the  elastography  scores  and  the  histology
esults.  In  our  study,  the  PPV  of  elastography  was  91.9%,
igher  than  results  from  the  literature  with  the  Tardivon
t  al.  study  ﬁnding  a  PPV  of  85.7%  [1].  The  NPV  of  elastogra-
hy  was  61.3%,  lower  than  the  results  found  in  the  Tardivon
t  al.  study  in  which  the  NPV  was  80.3%  [1].  The  sensitivity  of
lastography  was  73.9%,  slightly  lower  than  results  from  the
iterature  in  which  it  ranges  from  77.6%  to  86.5%  [1,18,19].
he  speciﬁcity  of  elastography  was  86.4%,  which  was  a  sim-
lar  result  to  those  in  the  literature  (from  84.7%  to  89.8%)
1,18,19].  The  results  from  our  study  show  higher  sensitivity
nd  speciﬁcity  for  the  elastography  colourimetry  score  with
s
t
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n  ROC  curve  showing  a  wide  area  under  the  curve  of  0.813.
eong  et  al.  had  similar  results,  with  an  area  under  the  curve
f  0.869  [1].  In  our  study,  of  the  12  false  negatives,  six  were
nvasive  ductal  cancers,  two  were  invasive  lobular  cancers,
ne  was  a  mucinous-type  and  one  was  a  ductal  carcinoma
n  situ.  These  results  are  consistent  with  those  in  the  lit-
rature.  In  the  Tardivon  et  al.  series  (61  malignant  lesions
nd  61  benign  lesions)  the  histology  of  the  13  false  nega-
ives  (scores  1,  2  and  3)  revealed  invasive  ductal  cancers
n  =  8),  invasive  lobular  cancers  (n  =  3),  one  mucinous-type
ancer  and  one  papillary  carcinoma  [1].  In  the  Giuseppetti
t  al.  series  (91  nodules),  the  histology  of  13  false  nega-
ives  (elastography  scores  of  2  and  3)  showed  mixed-type
nvasive  carcinomas  (n  =  6),  invasive  lobular  type  (n  =  3)  and
uctal  cancers  (n  =  4)  [18]. Our  study  showed  a  good  corre-
ation  between  the  elastography  scores  and  the  ﬁrmness  of
he  tissue  studied,  which  is  the  very  principle  of  this  tech-
ique.  Indeed  the  elastography  false  positives  were  found
mong  the  lesions  that  had  structures  with  a  ﬁrm  or  ﬁbrous
onsistency  meaning  that  they  were  assigned  an  inappro-
riately  high  score  (sclerosing  adenosis,  ﬁbrous  mastopathy,
adial  scar)  and  could  be  connected  to  lesions  being  partly
alciﬁed.
Of  the  12  false  negatives  found  on  elastography,  two
esions  were  lymph  node  tumour  proliferation  and  one  was
 lymphoma  localised  to  the  breast,  which  had  quite  soft
onsistencies.  This  could  be  because  they  contained  ﬂuid,
hich  would  explain  their  relative  softness  on  elastography.
here  was  one  mucinous  cancer  with  a  gelatinous  consis-
ency  due  to  abundant  mucous  secretion.  There  were  also
wo  lobular  cancers  and  one  cancer  in  situ.  For  these  latter
hree  lesions,  their  benign  colourimetry  score  is  explained
y  the  fact  that  there  was  no  desmoplastic  ﬁbrous  reaction.
Of  the  six  false  negatives  corresponding  to  invasive  ductal
arcinomas,  four  of  these  were  found  early  on  in  the  study
hen  the  operators  were  still  perfecting  their  technique.
hese  six  lesions  had  quite  disparate  sizes  (ranging  from  5
o  22  mm  with  one  lesion  of  20  mm  and  one  of  22  mm),  so  we
re  unable  to  state  that  size  has  an  inﬂuence  based  on  such
 limited  number  of  lesions,  although  in  the  literature  elas-
ography  is  reported  to  perform  better  for  lesions  smaller
han  20  mm  [18].
Our study  also  showed  the  Z2/Z1  ratio  to  have  increased
ensitivity  and  speciﬁcity  with  an  analysis  of  the  ROC  curve
howing  a  wide  area  under  the  curve  of  0.860  (Fig.  7).  The
igher  the  Z  ratio,  the  more  likely  the  histology  results  would
oint  to  a  malignant  lesion,  and  the  lower  the  Z2/Z1  ratio,
he  more  likely  it  was  that  the  histology  results  would  point
o  a  benign  lesion.  Since  the  aim  of  using  elastography  is  to
eturn  fewer  false  positives  and  more  true  negatives,  it  is
ssential  that  this  examination  has  higher  speciﬁcity  and  so
he  cut-off  point  of  the  Z2/Z1  ratio  was  set  at  3.05  to  cor-
espond  to  a  sensitivity  of  69.6%  and  a  speciﬁcity  of  99.0%.
n  the  literature  the  cut-off  point  is  slightly  higher,  at  4.3,
ith  a  speciﬁcity  of  88.8%  and  a  sensitivity  of  89.4%  [20].
he  histogram  is  an  interesting  complementary  resource  for
ssessing  the  stiffness  of  the  nodule  studied  according  to  the
istribution  pattern  of  its  ﬁrmness.  This  is  not  studied  in  thetiffness  being  concentrated  in  the  ﬁrst  column  of  the  his-
ogram  and  malignant  lesions.  A  concentration  of  lesion
tiffness  located  in  column  1  of  the  histogram  pointed  to  a
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malignant  lesion  (84.8%  of  malignant  lesions)  while  a  more
evenly  spread  distribution  and/or  being  located  in  column  2,
3,  4  or  5  pointed  to  a  benign  lesion.  The  whole  value  of  this
technique  rests  in  the  analysis  of  masses  classed  as  BI-RADS
4,  a  heterogeneous  group  within  which  the  cancer  rate  varies
from  30.0%  to  70.0%.  In  our  study,  of  the  25  lesions  classed  as
BI-RADS  4,  nine  turned  out  to  be  malignant  lesions.  A  malig-
nant  elastography  score  was  found  in  four  cases  out  of  nine.
In  two  of  these  nine  cases,  the  elastography  score  was  low
but  the  lesions  were  a  lymph  node  tumour  proliferation  and
a  lymphoma  localised  to  the  breast,  so  they  involved  breast
tissue  of  a  less  stiff  consistency.
The  study  had  some  limitations:  the  sample  was  small,
consisting  of  only  69  patients,  of  which  68  cases  were  ana-
lysed.  In  the  literature,  the  Tardivon  et  al.  study  covered
122  lesions,  Leong  et  al.  reviewed  99  lesions  and  Itoh  et  al.,
135  lesions.  The  study  was  conducted  in  the  Breast  Dis-
ease  department  at  the  Tours  CHRU  (regional  university
hospital)  on  a  population  that  differed  from  the  general  pop-
ulation,  which  explains  the  variation  found  in  histological
types  (lymphoma,  papillary,  mucinous  and  apocrine  carci-
nomas).  Four  operators  took  part  in  the  study  but  we  do  not
have  sufﬁcient  data  to  study  conclusively  the  reproducibil-
ity  of  the  elastography  assessments.  Use  of  this  technique
has  a  steep  learning  curve.  In  this  context,  it  is  important
to  note  that  nine  of  the  12  false  negatives  found  on  elas-
tography  arose  in  the  ﬁrst  30  days  of  the  study,  and  this
was  because  the  operators  were  still  perfecting  use  of  the
equipment.  This  phenomenon  is  also  found  in  the  litera-
ture  [1,16]. It  is  therefore  essential  that  operators  have
time  to  learn  how  to  use  the  equipment  because  a  rigorous
technique  requires  a  good  understanding  of  the  assessment
tools  (setting  the  ROI  in  the  structures  studied)  as  well
as  learning  the  decompression  technique.  The  technique
is  operator-dependent  because  the  mechanical  manoeuvres
that  need  to  be  carried  out  inﬂuence  the  image  and,  in
turn,  the  elastography  score,  which  could  be  a  source  of
interpretation  errors  and  the  reproducibility  of  the  results
is  difﬁcult  to  evaluate.  This  brings  us  to  another  limita-
tion,  which  is  that  the  dynamic  investigation  cannot  be
recorded  so  it  is  impossible  to  look  at  the  examinations
again.  This  means  that  any  quality  assessment  of  the  imag-
ing  carried  out  is  compromised,  as  is  the  validity  of  the
results.  Similarly,  assessing  the  progress  of  the  operators  as
they  learn  to  perform  the  examination  is  even  more  difﬁ-
cult.  Elastography  produces  qualitative  results,  dependent
on  the  compression  motion  applied  to  the  transducer,  which
may  vary  from  one  user  to  another.  A  new  technique  using
ShearWaveTM elastography  involves  the  transducer  itself  pro-
ducing  an  ultrasonic  shear  wave  and  measuring  how  quickly
it  propagates  to  the  tissues.  This  technique  requires  a  new
elastography  system  that  acquires  20,000  images  a  second.
This  new  imaging  technique  enables  tissue  elasticity  to  be
measured  in  real  time,  in  a  reproducible  way  that  is  not  user-
dependent  and  produces  quantitative  results  (in  kilopascals)
[21,22].
We  could  extend  this  study  to  cover  masses  of  indeter-
minate  nature  classed  as  BI-RADS  category  3  in  order  to
investigate  whether  elastography  could  lead  to  patients  not
having  to  undergo  repeated  monitoring  if  it  has  good  NPV,
or  perhaps  whether  it  could  guide  biopsies  and  give  weight
to  a  recommendation  for  repeated  monitoring  in  cases  of
[765
olid  lesions  with  no  morphological  ﬁndings  suspicious  for
alignancy.
onclusion
ur  study  proved  that  there  is  a  good  correlation  between
he  diagnostic  ﬁndings  of  static  elastography  of  the  breast  in
asses  classed  as  BI-RADS  4  and  BI-RADS  5  and  sonography,
sing  the  results  of  pathology  analyses  on  the  masses  as  a
eference,  with  a  PPV  of  91.9%.  Static  elastography  of  the
reast  is  a  reliable  technique  that  can  assist  radiologists  in
heir  approach  to  diagnosing  breast  pathologies.  It  is  simple
o  put  into  practice  on  a  daily  basis  because  it  retains  all  the
unctionality  of  traditional  sonography,  in  that  it  is  quick  to
arry  out  and  it  is  safe.  However,  this  technique  remains
ualitative  and  operator-dependent.
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